Περίληψη:
Objective: Current guidelines recommend that only validated devices for
blood pressure measurement should be used. This study presents the
validation results of the Microlife BPA100 Plus monitor for self-home
blood pressure measurement, according to the European Society of
Hypertension International Protocol.
Methods: Fifteen study participants were included in phase 1 and an
additional 18 in phase 2 (total 33). Simultaneous blood pressure
measurements were taken by two trained observers (Y tube connected
mercury sphygmomanometers) four times, sequentially with three
measurements taken using the tested device. Absolute differences between
observer and device blood pressure were classified into three zones
(within 5, 10 and 15 mmHg). The number of readings with a difference
within 5 mmHg was calculated for each individual.
Results: In phase 1, the device produced 32, 42 and 43 measurements
within 5, 10 and 15 mmHg, respectively, for systolic blood pressure and
31, 45 and 45 for diastolic blood pressure. In phase 2.1, the device
produced 71, 87 and 96 measurements within 5, 10 and 15 mmHg,
respectively, for systolic blood pressure, and 71, 98 and 99
measurements for diastolic blood pressure. In phase 2.2, 26 participants
had at least two of their differences within 5 mmHg and three
participants had no differences within 5 mmHg for systolic blood
pressure, whereas for diastolic blood pressure 24 and three
participants, respectively. Mean systolic blood pressure differences
were -2.0 +/- 6.0 mmHg and diastolic blood pressure differences were 3.1
+/- 4.1 mmHg.
Conclusions: The Microlife BPA100 Plus device for self-home blood
pressure measurement comfortably passes the validation requirements of
the International Protocol and therefore can be recommended for clinical
use in the adult population.
Συγγραφείς:
Stergiou, George S.
Giovas, Periklis R.
Neofytou, Michalis S.
and Adamopoulos, Dionysios N.
